Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

Drug repurposing for Alzheimer's disease: Selective serotonin reuptake inhibitors - Rao - 2020 - Alzheimer's & Dementia - Wiley Online Library

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

Otsuka and Lundbeck Announce REXULTI for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease